Cargando…
High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases
Ewing sarcoma (ES) develops in bones or soft tissues of children and adolescents. The presence of bone metastases is one of the most adverse prognostic factors, yet the mechanisms governing their formation remain unclear. As a transcriptional target of EWS-FLI1, the fusion protein driving ES transfo...
Autores principales: | Hong, Sung-Hyeok, Tilan, Jason U., Galli, Susana, Izycka-Swieszewska, Ewa, Polk, Taylor, Horton, Meredith, Mahajan, Akanksha, Christian, David, Jenkins, Shari, Acree, Rachel, Connors, Katherine, Ledo, Phuong, Lu, Congyi, Lee, Yi-Chien, Rodriguez, Olga, Toretsky, Jeffrey A., Albanese, Chris, Kitlinska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466675/ https://www.ncbi.nlm.nih.gov/pubmed/25714031 |
Ejemplares similares
-
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects
por: Tilan, Jason U., et al.
Publicado: (2013) -
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma
por: Lu, Congyi, et al.
Publicado: (2022) -
Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma
por: Lu, Congyi, et al.
Publicado: (2022) -
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
por: Czarnecka, Magdalena, et al.
Publicado: (2014) -
Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread
por: Sigorski, Dawid, et al.
Publicado: (2022)